デフォルト表紙
市場調査レポート
商品コード
1403497

クリティカルケア診断市場の2030年までの予測:製品、検査タイプ、エンドユーザー別、地域別の世界分析

Critical Care Diagnostics Market Forecasts to 2030 - Global Analysis By Product (Cancer Markers Testing Kit, Fecal Occult Testing Kits, Cholesterol Test Strips and Other Products), Test Type, End User and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.16円
クリティカルケア診断市場の2030年までの予測:製品、検査タイプ、エンドユーザー別、地域別の世界分析
出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、クリティカルケア診断の世界市場は2023年に12億9,000万米ドルを占め、2030年には18億8,000万米ドルに達すると予測され、予測期間中のCAGRは5.5%です。

クリティカルケア診断学は、生命を脅かすような病気を患い、早急な治療が必要とされる患者を正確かつ迅速に評価することを目的としています。この分野には、医療専門家が臓器機能、血液ガス、電解質などの重要なパラメータの最新データにアクセスできるようにすることを目的とした、さまざまな診断手順やモニタリング方法が含まれます。この分野では、迅速で正確な診断機器が、重症患者のモニタリングと評価、重点的な介入を可能にし、患者の転帰全体を向上させる上で大きな役割を果たしています。

米国医師会によると、米国はヘルスケアに4兆3,000億米ドルを費やしており、これは国民一人当たり12,194ドルに相当します。医療費全体の支出は、同年のGDPの約18.3%でした。

診断に対する意識の高まり

世界中のヘルスケアシステムが、重篤な状態への迅速な介入の重要性を認識しているため、高度な診断ツールや技術にますます焦点が当てられています。早期診断は患者の予後を改善し、医療従事者が焦点を絞ったタイムリーな介入を行えるようにすることで、医療資源に対する全体的な需要を軽減します。診断技術の向上もこの動向を後押ししており、その結果、より迅速で正確な検査方法が生み出されています。

発展途上地域における限られたアクセシビリティ

世界のクリティカルケア診断市場における大きな障壁は、新興国市場におけるアクセシビリティの低さです。これらの地域では、診断施設に必要なリソースの不足、熟練労働者の不足、不十分なヘルスケアインフラといった問題に頻繁に悩まされています。その結果、クリティカルケア診断へのアクセシビリティと費用対効果が損なわれ、迅速かつ正確な疾患診断が妨げられています。しかし、このような制約を回避し、発展途上国における重症患者診断のアクセシビリティを向上させるためには、ヘルスケアインフラへの投資拡大や集中的な能力開発プログラムなど、これらの問題に対処するための努力が必要です。

POCTソリューションへの需要の高まり

ポイント・オブ・ケア検査(POCT)ソリューションに対するニーズの高まりは、世界の救命救急診断薬市場に大きな機会をもたらしています。救命医療の現場では、迅速かつ正確な診断結果が重視されるようになっています。POCTは、医療専門家が患者のケアについてタイムリーな判断を下すのに役立ちます。患者の予後を改善するため、この動向は重症患者診断の迅速化と効率化の必要性によって動機づけられています。また、高度な分子検査や携帯型診断装置のような最先端技術の導入も市場の成長を後押ししています。世界のヘルスケアシステムがクリティカルケアを効率的に提供することを優先しているため、革新的な診断ソリューションの需要が高まっています。

診断技術の複雑化

最先端の診断技術を開発するための複雑さと費用の増大は、世界の重症患者診断市場に深刻な脅威を与えています。より正確で洗練された救命救急診断薬への需要が高まるにつれ、研究開発に関連するコスト、規制がもたらす障害、専門知識の必要性など、業界は困難に直面しています。しかし、ヘルスケア償還と政策状況の変化は、市場拡大に影響を及ぼし、メーカーに課題をもたらし、新規診断技術の取り込みを阻害する可能性があります。

COVID-19の影響:

COVID-19の大流行により、診断機器・装置に対する需要が急増しています。クリティカルケア診断技術は、迅速かつ正確な検査の必要性による技術革新と進歩により進歩しました。分子診断、画像ソリューション、ポイントオブケア検査機器の研究開発費は増加しています。重症患者の管理における早期かつ正確な診断の重要性がパンデミックによって強調された結果、重症患者診断ソリューションがより重視されるようになった。

予測期間中、妊娠・不妊検査キット分野が最大となる見込み

妊娠・不妊検査キット分野は急速なペースで成長すると推定されます。妊娠・不妊検査キット分野は、妊娠と不妊に関連するパラメーターを測定・追跡するために作られた診断機器に焦点を当てています。これらの検査キットは、妊娠の早期発見や不妊についての啓蒙に不可欠です。血液や尿分析のような様々な技術を使用するこれらの検査は、家族計画や迅速な介入を可能にする正確な結果をもたらします。さらに、これらのキットの需要は、リプロダクティブ・ヘルスに対する意識の高まりとともに、自己モニタリングの傾向が高まっていることが背景にあります。

微生物学・感染症検査分野は予測期間中に最も高いCAGRが見込まれる

微生物学・感染症検査分野は、感染症の原因となる微生物病原体を同定・分析することから、有利な成長が見込まれます。この重要な分野は、細菌、ウイルス、真菌、寄生虫を検出するために、血液、尿、組織サンプルなどの様々な検体を検査します。ポリメラーゼ連鎖反応(PCR)や免疫測定法(イムノアッセイ)のような高度な診断技術を活用することで、ヘルスケア専門家は感染症を迅速かつ正確に診断することができます。さらに、分子技術や自動化の進展により、クリティカルケア診断における微生物学的検査や感染症検査の効率と精度がさらに向上しています。

最大のシェアを占める地域

慢性疾患の罹患率の上昇と高度なヘルスケアシステムの結果、北米地域ではクリティカルケア診断市場が大きく成長しています。呼吸器疾患や心臓疾患などの疾病の有病率の増加により、クリティカルケア診断のニーズが高まっています。同地域では疾病の早期発見が重視され、ヘルスケア支出も高いことから、クリティカルケア診断の成長が促進されています。さらに北米は、迅速な診断と治療の重要性を強調する政府の取り組みや啓発キャンペーンにも深く影響を受けています。

CAGRが最も高い地域:

欧州地域は、人口の高齢化、重篤な医療現場における迅速かつ正確な診断検査の必要性など、さまざまな要因の結果として市場の成長を経験しています。クリティカルケア診断機器の品質、安全性、有効性を確保するための規制措置が実施され、技術革新が促進され、地域の成長を牽引しています。厳しい承認プロセスと高品質基準の遵守により、この分野の企業による研究開発への投資が増加しています。さらに、欧州では、主要な業界参加企業と学術機関との提携や、重症患者診断への支援が継続的に行われています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます:

  • 企業プロファイル
    • 追加市場企業の包括的プロファイリング(3社まで)
    • 主要企業のSWOT分析(3社まで)
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR(注:フィージビリティチェックによる)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症(COVID-19)の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界のクリティカルケア診断市場:製品別

  • がんマーカー検査キット
  • 便潜血検査キット
  • コレステロールテストストリップ
  • 薬物乱用検査キット
  • 妊娠および生殖能力検査キット
  • 心臓代謝モニタリングキット
  • 感染症検査キット
  • グルコースモニタリングキット
  • その他の製品

第6章 世界のクリティカルケア診断市場:検査タイプ別

  • フローサイトメトリー
  • 血液学検査
  • 凝固検査
  • 微生物と感染症検査
  • 免疫タンパク質
  • 日常および特別な化学
  • その他の検査タイプ

第7章 世界のクリティカルケア診断市場:エンドユーザー別

  • 手術室
  • 集中治療室
  • 救急処置室
  • その他のエンドユーザー

第8章 世界のクリティカルケア診断市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他のアジア太平洋
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他の南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他の中東・アフリカ

第9章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第10章 企業プロファイル

  • Abbott Laboratories
  • Alere, Inc.
  • Bayer Healthcare AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BioMerieux, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biosensors Japan Co., Ltd.
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics Holdings PLC
  • Nanomix, Inc.
  • Nova Biomedical Corporation
  • Roche Diagnostics AG
  • Siemens Healthineers
  • Sysmex Corporation
図表

List of Tables

  • Table 1 Global Critical Care Diagnostics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 4 Global Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 5 Global Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 6 Global Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 7 Global Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 8 Global Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 9 Global Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 10 Global Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 11 Global Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 12 Global Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 13 Global Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 14 Global Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 15 Global Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 16 Global Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 17 Global Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 18 Global Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 19 Global Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 20 Global Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 22 Global Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 23 Global Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 24 Global Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 27 North America Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 28 North America Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 29 North America Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 30 North America Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 31 North America Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 32 North America Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 33 North America Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 34 North America Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 35 North America Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 36 North America Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 37 North America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 38 North America Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 39 North America Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 40 North America Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 41 North America Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 42 North America Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 43 North America Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 44 North America Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 45 North America Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 46 North America Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 47 North America Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 48 North America Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 51 Europe Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 52 Europe Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 53 Europe Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 54 Europe Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 55 Europe Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 56 Europe Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 57 Europe Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 58 Europe Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 59 Europe Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 60 Europe Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 61 Europe Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 62 Europe Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 63 Europe Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 64 Europe Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 65 Europe Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 66 Europe Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 67 Europe Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 68 Europe Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Europe Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 70 Europe Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 71 Europe Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 72 Europe Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 Asia Pacific Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 76 Asia Pacific Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 77 Asia Pacific Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 78 Asia Pacific Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 79 Asia Pacific Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 80 Asia Pacific Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 81 Asia Pacific Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 82 Asia Pacific Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 83 Asia Pacific Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 84 Asia Pacific Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 85 Asia Pacific Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 86 Asia Pacific Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 87 Asia Pacific Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 88 Asia Pacific Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 89 Asia Pacific Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 90 Asia Pacific Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 91 Asia Pacific Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 92 Asia Pacific Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 Asia Pacific Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 94 Asia Pacific Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 95 Asia Pacific Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 96 Asia Pacific Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 99 South America Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 100 South America Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 101 South America Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 102 South America Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 103 South America Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 104 South America Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 105 South America Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 106 South America Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 107 South America Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 108 South America Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 109 South America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 110 South America Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 111 South America Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 112 South America Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 113 South America Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 114 South America Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 115 South America Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 116 South America Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 117 South America Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 118 South America Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 119 South America Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 120 South America Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 123 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 124 Middle East & Africa Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 125 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 126 Middle East & Africa Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 127 Middle East & Africa Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 128 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 129 Middle East & Africa Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 130 Middle East & Africa Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 131 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 132 Middle East & Africa Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 133 Middle East & Africa Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 134 Middle East & Africa Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 135 Middle East & Africa Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 136 Middle East & Africa Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 137 Middle East & Africa Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 138 Middle East & Africa Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 139 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 140 Middle East & Africa Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 141 Middle East & Africa Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 142 Middle East & Africa Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 143 Middle East & Africa Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 144 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
目次
Product Code: SMRC24722

According to Stratistics MRC, the Global Critical Care Diagnostics Market is accounted for $1.29 billion in 2023 and is expected to reach $1.88 billion by 2030 growing at a CAGR of 5.5% during the forecast period. Critical care diagnostics is devoted to assessing patients accurately and quickly who have life-threatening illnesses that frequently call for immediate treatment. This area of study includes a variety of diagnostic procedures and monitoring methods intended to give medical professionals access to up-to-date data on critical parameters like organ function, blood gases, and electrolytes. In this field, quick and accurate diagnostic instruments play a major role in monitoring and assessing critically ill patients, enabling focused interventions, and enhancing overall patient outcomes.

According to America Medical Association, the U.S. spent USD 4.3 trillion on healthcare, which equates to USD 12,194 per capita. The overall health spending was around 18.3% of the GDP in the same year.

Market Dynamics:

Driver:

Increased awareness on diagnosis

An increasing focus is being placed on advanced diagnostic tools and technologies as healthcare systems across the globe acknowledge the significance of prompt intervention in critical conditions. Early diagnosis improves patient outcomes and lessens the overall demand on healthcare resources by allowing medical professionals to launch focused, timely interventions. Improvements in diagnostic techniques are also driving this trend, resulting in the creation of testing methods that are faster and more accurate.

Restraint:

Limited accessibility in developing regions

A major barrier to the global critical care diagnostics market is the lack of accessibility in developing nations. These areas frequently struggle with issues like a lack of resources for diagnostic facilities, a shortage of skilled workers, and inadequate healthcare infrastructure. Consequently, there are compromises in the accessibility and cost-effectiveness of critical care diagnostics, impeding prompt and precise disease diagnosis. However, to get around this restriction and enhance the accessibility of critical care diagnostics in developing nations, efforts must be made to address these issues, such as through increased investment in healthcare infrastructure and focused capacity-building programs.

Opportunity:

Growing demand for POCT solutions

The increasing need for point-of-care testing (POCT) solutions presents a major opportunity in the global critical care diagnostics market. In critical care settings, there is a growing focus on quick and accurate diagnostic results. POCT helps medical professionals make timely decisions about patient care. In order to improve patient outcomes, this trend is motivated by the need to expedite critical care diagnostics and increase their efficiency. The market's growth is also aided by the uptake of cutting-edge technologies like sophisticated molecular testing and portable diagnostic devices. Innovative diagnostic solutions are in high demand as global healthcare systems prioritize providing critical care efficiently.

Threat:

Increasing complexity associated with diagnostic technologies

The growing complexity and expense of creating cutting-edge diagnostic technologies pose a serious threat to the global critical care diagnostics market. The industry faces difficulties with regard to costs associated with research and development, obstacles posed by regulations, and the requirement for specialized knowledge as the demand for more accurate and sophisticated critical care diagnostics increases. However, changing healthcare reimbursement and policy landscapes may have an effect on market expansion, posing challenges for manufacturers and impeding the uptake of novel diagnostic technologies.

COVID-19 Impact:

The COVID-19 pandemic has caused a sharp increase in demand for diagnostic instruments and equipment. Critical care diagnostics technology has advanced due to innovation and advancements driven by the need for fast and accurate testing. Research and development expenditures for molecular diagnostics, imaging solutions, and point-of-care testing devices have increased. A greater emphasis on critical care diagnostic solutions has resulted from the pandemic's emphasis on the significance of early and accurate diagnostics in the management of critically ill patients.

The pregnancy and fertility testing kits segment is expected to be the largest during the forecast period

The pregnancy and fertility testing kits segment is estimated to grow at a rapid pace. The pregnancy and fertility testing kits segment focuses on diagnostic instruments made to measure and track parameters related to pregnancy and fertility. These kits are essential for early pregnancy detection and for educating people about their fertility. These tests, which use different techniques like blood or urine analysis, yield precise results that allow for family planning and prompt intervention. Additionally, the demand for these kits has been driven by the rising trend of self-monitoring along with increased awareness of reproductive health.

The microbiology and infectious test segment is expected to have the highest CAGR during the forecast period

The microbiology and infectious test segment is expected to hold lucrative growth as it identifies and analyzes microbial pathogens responsible for infectious diseases. This crucial segment involves the examination of various specimens, such as blood, urine, and tissue samples, to detect bacteria, viruses, fungi, and parasites. Utilizing advanced diagnostic technologies like polymerase chain reaction (PCR) and immunoassays, healthcare professionals can rapidly and accurately diagnose infectious conditions. Additionally, the ongoing advancements in molecular techniques and automation further enhance the efficiency and precision of microbiological and infectious tests in critical care diagnostics.

Region with largest share:

The market for critical care diagnostics has grown substantially in the North American region as a result of rising rates of chronic illness and sophisticated healthcare systems. The need for critical care diagnostics has increased due to the growing prevalence of illnesses like respiratory and cardiac disorders. The growth of critical care diagnostics has been facilitated by the region's emphasis on early disease detection and high healthcare spending. Moreover, North America has also been deeply influenced by government initiatives and awareness campaigns that highlight the significance of prompt diagnosis and treatment.

Region with highest CAGR:

The European region has experienced growth in the market as a result of various factors, including population aging, need for quick and precise diagnostic testing in critical care settings. Regulatory measures have been implemented to ensure the quality, safety, and efficacy of critical care diagnostic devices, fostering innovation and driving regional growth. Stringent approval processes and adherence to high-quality standards have led to increased investment in research and development by companies in the sector. In addition, partnerships between major industry participants and academic institutions and support for critical care diagnostics continued in Europe.

Key players in the market:

Some of the key players in Critical Care Diagnostics market include Abbott Laboratories, Alere, Inc., Bayer Healthcare AG, Beckman Coulter, Inc., Becton, Dickinson and Company, BioMerieux, Inc., Bio-Rad Laboratories, Inc., Biosensors Japan Co., Ltd., Chembio Diagnostic Systems, Inc., EKF Diagnostics Holdings PLC, Nanomix, Inc., Nova Biomedical Corporation, Roche Diagnostics AG, Siemens Healthineers and Sysmex Corporation.

Key Developments:

In December 2023, Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies. The Agreement is based on a basic agreement on business collaboration in the field of immunoassay*1 which the two companies signed.

In March 2023, ABEC announced it will provide customized, large-scale bioprocess equipment, including a 14,500-liter total volume stainless steel fermenter and an 8,000 liter media preparation system to EKF Life Sciences, a division of EKF Diagnostics Holdings plc. The agreement provides EKF Life Sciences' South Bend, Indiana facility with the bioprocess equipment which will significantly expand EKF's production capacity of enzymes used in a variety of diagnostic and Life Science applications.

Products Covered:

  • Cancer Markers Testing Kit
  • Fecal Occult Testing Kits
  • Cholesterol Test Strips
  • Drugs Of Abuse Testing Kits
  • Pregnancy and Fertility Testing Kits
  • Cardiometabolic Monitoring Kits
  • Infectious Disease Testing Kits
  • Glucose Monitoring Kits
  • Other Products

Test Types Covered:

  • Flow Cytometry
  • Hematology Test
  • Coagulation Test
  • Microbiology and Infectious Test
  • Immunoprotein
  • Routine and Special Chemistry
  • Other Test Types

End Users Covered:

  • Operating Room
  • Intensive Care Unit
  • Emergency Room
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Critical Care Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Cancer Markers Testing Kit
  • 5.3 Fecal Occult Testing Kits
  • 5.4 Cholesterol Test Strips
  • 5.5 Drugs Of Abuse Testing Kits
  • 5.6 Pregnancy and Fertility Testing Kits
  • 5.7 Cardiometabolic Monitoring Kits
  • 5.8 Infectious Disease Testing Kits
  • 5.9 Glucose Monitoring Kits
  • 5.10 Other Products

6 Global Critical Care Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Flow Cytometry
  • 6.3 Hematology Test
  • 6.4 Coagulation Test
  • 6.5 Microbiology and Infectious Test
  • 6.6 Immunoprotein
  • 6.7 Routine and Special Chemistry
  • 6.8 Other Test Types

7 Global Critical Care Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Operating Room
  • 7.3 Intensive Care Unit
  • 7.4 Emergency Room
  • 7.5 Other End Users

8 Global Critical Care Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Alere, Inc.
  • 10.3 Bayer Healthcare AG
  • 10.4 Beckman Coulter, Inc.
  • 10.5 Becton, Dickinson and Company
  • 10.6 BioMerieux, Inc.
  • 10.7 Bio-Rad Laboratories, Inc.
  • 10.8 Biosensors Japan Co., Ltd.
  • 10.9 Chembio Diagnostic Systems, Inc.
  • 10.10 EKF Diagnostics Holdings PLC
  • 10.11 Nanomix, Inc.
  • 10.12 Nova Biomedical Corporation
  • 10.13 Roche Diagnostics AG
  • 10.14 Siemens Healthineers
  • 10.15 Sysmex Corporation